Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 265840, 11 pages
http://dx.doi.org/10.1155/2014/265840
Research Article

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

1Department of Functional Biology, IUOPA, University of Oviedo, Facultad de Medicina, Julian Claveria sn, 33006 Oviedo, Spain
2Department of Hematology, Hospital Universitario Central de Asturias, C/Celestino Villamil s/n, 33006 Oviedo, Spain

Received 11 February 2014; Revised 21 July 2014; Accepted 5 August 2014; Published 17 September 2014

Academic Editor: Gerassimos A. Pangalis

Copyright © 2014 Andrea Acebes-Huerta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Andrea Acebes-Huerta, Leticia Huergo-Zapico, Ana Pilar Gonzalez-Rodriguez, et al., “Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells,” BioMed Research International, vol. 2014, Article ID 265840, 11 pages, 2014. https://doi.org/10.1155/2014/265840.